TARO LVT 250 (Levetiracetam 250 mg)

Pill imprint TARO LVT 250 has been identified as Levetiracetam 250 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; neuralgia; new daily persistent headache (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TARO LVT 250

Levetiracetam
Imprint:
TARO
LVT 250
Strength:
250 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Taro Pharmaceuticals U.S.A., Inc.
National Drug Code (NDC):
51672-4141
Inactive Ingredients:
silicon dioxide
corn starch
magnesium stearate
povidone
magnesium silicate
FD&C Blue No. 2
indigotindisulfonate sodium
aluminum oxide
hypromelloses
polyethylene glycol
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)